Stephen was counsel on the approval of a settlement against a drug manufacturer arising from the failure to disclose harmful side effects associated with a dopamine agonist medication used to treat Parkinson’s Disease. See Banerjee v. Shire Biochem Inc., 2011 ONSC 7616 (CanLII).
BANERJEE V. SHIRE BIOCHEM INC.
Stay Informed
Subscribe to receive updates on the latest news from Thomson Rogers LLP as well as invitations to seminars, webinars and more.
